IN VITRO OPIOID DETERMINATIONS FOR MEDICATIONS DEVELOPMENT

NIH GUIDE, Volume 22, Number 42, November 19, 1993



RFP AVAILABLE:  N01DA-4-8307



P.T. 34



Keywords:

  Opiates 

  Receptors 

  Bioassay 



National Institute on Drug Abuse



The National Institute on Drug Abuse (NIDA) is soliciting proposals

from qualified organizations having in-house capability to perform in

vitro opioid receptor binding and functional activity assays.

Proprietary test compounds will be evaluated in established assays,

and the resulting data will be utilized by the Opiate Treatment

Discovery Program of the NIDA Medications Development Division.



In addition, the successful offeror will devote a substantial number

of person hours to the development of new opioid receptor binding and

functional activity assays.  Offerors must indicate possession of

current DEA registration for Schedule II-V substances prior to award

and apply for Schedule I registration at the time of award.  It is

estimated that a three-year contract, which will include options for

additional studies, will result from this procurement.  Estimated

issuance date of Request for Proposals (RFP) No. N01DA-4-8307 is

November 22, 1993, and responses are due to be received in the

Contracting Office 45 calendar days thereafter.



INQUIRIES



Written requests are to be forwarded to:



Jeffrey Weiner, Contract Specialist

National Institute on Drug Abuse

Parklawn Building, Room 10-49

5600 Fishers Lane

Rockville, MD  20857



This advertisement does not commit the Government to make an award.



.

Return to 1993 Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.